On August 26, 2019, the China’s National People’s Congress passed the amended Drug Administration Law (the Amended DAL) which will take effect on December 1.
The new law brings in some changes while codifying many existing practices. We summarize the key highlights, including intellectual property related rules, of the Amended DAL.
Please see full publication below for more information.